ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

February 29, 2008

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

ACCC Annual Meeting Jan. 27-29; Upton To speak

November 4, 1977

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992